title: Development of a TT virus DNA quantification system using real-time detection PCR.
abstract: Although TT virus (TTV) was isolated from a cryptogenic posttransfusion hepatitis patient, its pathogenic role remains unclear. It has been reported that the majority of the healthy population is infected with TTV. To elucidate the differences between TTV infection in patients with liver diseases and TTV infection in the healthy population, a quantification system was developed. TTV DNA was quantified by a real-time detection PCR (RTD-PCR) assay on an ABI Prism 7700 sequence detector. With this system, TTV DNA was quantified in 78 hepatitis C virus (HCV)-infected patients (63 with elevated serum alanine aminotransferase [ALT] levels and 15 with normal ALT levels) and in 70 voluntary blood donors (BDs). The quantification range was 2.08 to 7.35 log copies/ml. The intra-assay and interassay coefficients of variation were 0.37 to 6.33% and 0.60 to 7.07%, respectively. The mean serum TTV DNA levels in the HCV-infected patients with both elevated and normal ALT levels and BDs were 3.69 +/- 0.89, 3.45 +/- 0.76, and 3.45 +/- 0.67 log copies/ml, respectively. Comparison of the serum TTV DNA levels among the HCV-infected patients revealed that they were not related to the serum ALT and HCV core protein levels or to the histopathological score on liver biopsy. This study showed that (i) the RTD-PCR assay for the detection of TTV was accurate and had a high degree of sensitivity, (ii) the mean serum TTV DNA level was similar among HCV-infected patients, irrespective of their ALT level, and also among BDs, and (iii) a high serum TTV DNA level does not affect the serum ALT and HCV levels or liver damage in HCV-infected patients.
authors.affiliation: Second Department of Medicine, Nagoya City University Medical School, Nagoya, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Kato
authors.forename: M
authors.initials: M
authors.lastname: Mizokami
authors.forename: M
authors.initials: M
authors.lastname: Mukaide
authors.forename: E
authors.initials: E
authors.lastname: Orito
authors.forename: T
authors.initials: T
authors.lastname: Ohno
authors.forename: T
authors.initials: T
authors.lastname: Nakano
authors.forename: Y
authors.initials: Y
authors.lastname: Tanaka
authors.forename: H
authors.initials: H
authors.lastname: Kato
authors.forename: F
authors.initials: F
authors.lastname: Sugauchi
authors.forename: R
authors.initials: R
authors.lastname: Ueda
authors.forename: N
authors.initials: N
authors.lastname: Hirashima
authors.forename: K
authors.initials: K
authors.lastname: Shimamatsu
authors.forename: M
authors.initials: M
authors.lastname: Kage
authors.forename: M
authors.initials: M
authors.lastname: Kojiro
mesh_terms: D001782:Blood Donors; D004266:DNA Virus Infections / Q000097:blood / Q000175:diagnosis*; D004279:DNA, Viral / Q000302:isolation & purification*; D006526:Hepatitis C / Q000821:virology; D006801:Humans; D016133:Polymerase Chain Reaction / Q000379:methods*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D065227:Transfusion Reaction
chemical_list: D004279:DNA, Viral